ClinicaliQ Trial Snapshot
- EORTC Metastatic Breast Cancer Module Development — Recruiting • Oncology • NCT07806266.
- What is being tested: Development of a specialised Health-Related Quality of Life (HRQOL) measurement module specifically designed for metastatic breast cancer patients, addressing the current lack of disease-specific assessment tools.
- Patient eligibility overview: The study targets metastatic breast cancer patients across varied disease stages and treatment contexts, ensuring the tool captures relevant quality of life concerns across the heterogeneous MBC population.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
The overall aim of this project is to help improve the Health Related Quality of Life (HRQOL) of metastatic breast cancer (MBC) patients. There is currently an urgent and unmet need for specific tools to aid in the evaluation of HRQOL in MBC and this project aims to address these needs by developing a comprehensive EORTC questionnaire for assessing the HRQOL of this group. The new module will be used in conjunction with EORTC QLQ-C30 and will provide better measurement of the quality of life issues experienced by women with…
Eligibility Snapshot
- : * Adult females aged 18 years or over. * Have a diagnosis of MBC (Breast cancer that has spread to another part of the body), including de novo MBC patients. Patients with brain metastases will be included, providing there is no associated major cognitive impairment. * Have received (patients under observation) or currently receiving treatment for MBC, including chemotherapy, hormone therapy, targeted agents (anti-HER2, CDK4/6 inhibitors, mTOR/PIK3CA inhibitors, PARP inhibitors, immune therapy), radiotherapy and combinations. * Conversant in the language of questionnaire administration. * Have the capacity to give informed consent.
Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.